483 NATCO Pharma Jan 2017

483 NATCO Pharma Jan 2017

Linda Murphy FDA, Anastasia Shields FDA$119.00 - Available Now

FDA investigators audited the NATCO Pharma - Mahaboob Nagar, India facility and issued 6 inspectional observations (via FDA 483) on 24 Jan 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 24 Jan 2017
  • Location: Mahaboob Nagar, India
  • FEI: 3004540906
Add To Cart